AMGN logo

Amgen Inc

AMGN

AMGN: Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amjevita (biosimilar Humira).

more

Show AMGN Financials

$AMGN is featured in our Shelley Moore Capito strategy.

See All Strategies
All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of AMGN by members of U.S. Congress

Politician Type Traded
Capito, Shelley Moore Senate / R Sale (Full) $1,001 - $15,000 Jun. 12, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 01, 2023
Kathy Manning House / D Purchase $1,001 - $15,000 Apr. 28, 2023
Josh Gottheimer House / D Purchase $1,001 - $15,000 Apr. 12, 2023
Michael C. Burgess House / R Purchase $15,001 - $50,000 Apr. 05, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Mar. 27, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Mar. 06, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Feb. 22, 2023
Josh Gottheimer House / D Sale $1,001 - $15,000 Jan. 27, 2023
Josh Gottheimer House / D Purchase $1,001 - $15,000 Dec. 09, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Oct. 19, 2022
Kathy Manning House / D Sale $1,001 - $15,000 Oct. 12, 2022
Tuberville, Tommy Senate / R Purchase $1,001 - $15,000 Oct. 06, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Sep. 26, 2022
Richard W. Allen House / R Purchase $15,001 - $50,000 Aug. 18, 2022
Kathy Manning House / D Sale $1,001 - $15,000 Aug. 03, 2022
Kathy Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy Manning House / D Sale $1,001 - $15,000 Jul. 27, 2022
Kathy Manning House / D Sale $1,001 - $15,000 Jul. 27, 2022
Kathy Manning House / D Purchase $1,001 - $15,000 Jul. 20, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 May. 11, 2022
Earl Blumenauer House / D Sale $1,001 - $15,000 Mar. 14, 2022
Josh Gottheimer House / D Purchase $1,001 - $15,000 Mar. 03, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 24, 2022
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Feb. 22, 2022
John Rutherford House / R Sale $1,001 - $15,000 Feb. 17, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 11, 2022
Tuberville, Tommy Senate / R Purchase $1,001 - $15,000 Jan. 12, 2022
Capito, Shelley Moore Senate / R Purchase $1,001 - $15,000 Dec. 15, 2021
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Jul. 19, 2021
Kathy Manning House / D Purchase $1,001 - $15,000 Apr. 30, 2021
Carol Devine Miller House / R Purchase $15,001 - $50,000 Mar. 04, 2021
Mr. Peter Meijer House / R Sale $1,001 - $15,000 Feb. 16, 2021
Kathy Manning House / D Sale $1,001 - $15,000 Jan. 15, 2021
Kathy Manning House / D Sale $1,001 - $15,000 Jan. 15, 2021
Josh Gottheimer House / D Sale $1,001 - $15,000 Oct. 22, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 Oct. 08, 2020
Carol Devine Miller House / R Purchase $15,001 - $50,000 Jul. 28, 2020
John A. Yarmuth House / D Purchase $1,001 - $15,000 May. 29, 2020
John A. Yarmuth House / D Sale $1,001 - $15,000 May. 29, 2020
Josh Gottheimer House / D Sale $1,001 - $15,000 May. 15, 2020
Earl Blumenauer House / D Purchase $1,001 - $15,000 May. 01, 2020
Loeffler, Kelly Senate / R Sale (Full) $250,001 - $500,000 Apr. 07, 2020
Loeffler, Kelly Senate / R Purchase $15,001 - $50,000 Apr. 07, 2020
Cassidy, Bill Senate / R Sale (Partial) $1,001 - $15,000 Mar. 09, 2020
Loeffler, Kelly Senate / R Sale (Full) $15,001 - $50,000 Mar. 04, 2020
Loeffler, Kelly Senate / R Sale (Full) $15,001 - $50,000 Mar. 04, 2020
Mikie Sherrill House / D Sale $1,001 - $15,000 Feb. 20, 2020
Josh Gottheimer House / D Purchase $1,001 - $15,000 Jan. 14, 2020
Michael John Gallagher House / R Sale $1,001 - $15,000 Jan. 09, 2020

Recently reported changes by institutional investors

Quarterly net insider trading by AMGN's directors and management

Government lobbying spending instances

  • $1,950,000 Jul 21, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2023 Issue: Health Issues
  • $60,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Jul 19, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $50,000 Jul 19, 2023 Issue: Health Issues
  • $60,000 Jul 18, 2023 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues
  • $60,000 Jul 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
  • $2,800,000 Apr 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $60,000 Apr 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Medicare/Medicaid
  • $50,000 Apr 20, 2023 Issue: Health Issues
  • $60,000 Apr 19, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Apr 19, 2023 Issue: Health Issues
  • $60,000 Apr 19, 2023 Issue: Trade (domestic/foreign) Budget/Appropriations Medicare/Medicaid Health Issues
  • $50,000 Apr 17, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Jan 20, 2023 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $2,140,000 Jan 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2023 Issue: Health Issues
  • $80,000 Jan 20, 2023 Issue: Taxation/Internal Revenue Code Health Issues Medicare/Medicaid
  • $50,000 Jan 19, 2023 Issue: Health Issues
  • $80,000 Jan 14, 2023 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $80,000 Oct 20, 2022 Issue: Medicare/Medicaid
  • $60,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Oct 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2022 Issue: Health Issues
  • $50,000 Oct 19, 2022 Issue: Health Issues
  • $3,150,000 Oct 18, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $80,000 Oct 16, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $60,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,200,000 Jul 20, 2022 Issue: Trade (domestic/foreign) Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $2,410,000 Jul 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Jul 20, 2022 Issue: Health Issues
  • $80,000 Jul 20, 2022 Issue: Medicare/Medicaid
  • $60,000 Jul 19, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $50,000 Jul 19, 2022 Issue: Health Issues
  • $80,000 Jul 15, 2022 Issue: Communications/Broadcasting/Radio/TV Health Issues Medicare/Medicaid
  • $60,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $60,000 Apr 20, 2022 Issue: Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $2,780,000 Apr 20, 2022 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Medicare/Medicaid Health Issues
  • $50,000 Apr 20, 2022 Issue: Health Issues
  • $80,000 Apr 20, 2022 Issue: Medicare/Medicaid
  • $50,000 Apr 19, 2022 Issue: Health Issues
  • $80,000 Apr 15, 2022 Issue: Health Issues Medicare/Medicaid
  • $70,000 Jan 21, 2022 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
  • $2,410,000 Jan 20, 2022 Issue: None
  • $50,000 Jan 20, 2022 Issue: Health Issues
  • $80,000 Jan 19, 2022 Issue: Medicare/Medicaid
  • $50,000 Jan 19, 2022 Issue: Health Issues
  • $80,000 Jan 18, 2022 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $80,000 Jan 15, 2022 Issue: None
  • $70,000 Oct 20, 2021 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
  • $2,620,000 Oct 20, 2021 Issue: None
  • $80,000 Oct 20, 2021 Issue: Copyright/Patent/Trademark Medicare/Medicaid Health Issues
  • $50,000 Oct 20, 2021 Issue: Health Issues
  • $50,000 Oct 18, 2021 Issue: Health Issues
  • $80,000 Oct 18, 2021 Issue: None
  • $80,000 Oct 15, 2021 Issue: Health Issues Medicare/Medicaid
  • $80,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $70,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $1,910,000 Jul 20, 2021 Issue: None
  • $50,000 Jul 20, 2021 Issue: Health Issues
  • $80,000 Jul 19, 2021 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
  • $50,000 Jul 19, 2021 Issue: Health Issues
  • $80,000 Jul 17, 2021 Issue: None
  • $2,810,000 Apr 20, 2021 Issue: None
  • $80,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $80,000 Apr 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2021 Issue: Health Issues
  • $50,000 Apr 19, 2021 Issue: Health Issues
  • $80,000 Apr 18, 2021 Issue: Medicare/Medicaid Health Issues
  • $80,000 Apr 17, 2021 Issue: MEDICARE/MEDICAID
  • $60,000 Jan 21, 2021 Issue: Medicare/Medicaid
  • $50,000 Jan 21, 2021 Issue: Health Issues
  • $80,000 Jan 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $50,000 Jan 20, 2021 Issue: Health Issues
  • $2,560,000 Jan 20, 2021 Issue: None
  • $80,000 Jan 19, 2021 Issue: Health Issues Medicare/Medicaid
  • $80,000 Jan 19, 2021 Issue: MEDICARE/MEDICAID
  • $60,000 Oct 20, 2020 Issue: Medicare/Medicaid
  • $2,920,000 Oct 20, 2020 Issue: None
  • $80,000 Oct 20, 2020 Issue: MEDICARE/MEDICAID
  • $50,000 Oct 20, 2020 Issue: Health Issues
  • $50,000 Oct 20, 2020 Issue: Health Issues
  • $80,000 Oct 19, 2020 Issue: Health Issues Medicare/Medicaid
  • $80,000 Oct 19, 2020 Issue: Health Issues Medicare/Medicaid
  • $2,970,000 Jul 20, 2020 Issue: None
  • $80,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $80,000 Jul 20, 2020 Issue: MEDICARE/MEDICAID
  • $60,000 Jul 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2020 Issue: Health Issues
  • $50,000 Jul 18, 2020 Issue: Health Issues
  • $80,000 Jul 14, 2020 Issue: Health Issues Medicare/Medicaid
  • $2,700,000 Apr 20, 2020 Issue: None
  • $50,000 Apr 20, 2020 Issue: Health Issues
  • $80,000 Apr 20, 2020 Issue: MEDICARE/MEDICAID
  • $60,000 Apr 20, 2020 Issue: Medicare/Medicaid
  • $80,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $50,000 Apr 19, 2020 Issue: Health Issues
  • $80,000 Apr 17, 2020 Issue: Health Issues Medicare/Medicaid
  • $2,400,000 Jan 21, 2020 Issue: None
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

WallStreetBets

Number of mentions of AMGN in WallStreetBets Daily Discussion

AMGN News

Recent insights relating to AMGN

CNBC Recommendations

Recent picks made for AMGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMGN

Corporate Flights

Flights by private jets registered to AMGN